Literature DB >> 15071390

Osmole gap in neurologic-neurosurgical intensive care unit: Its normal value, calculation, and relationship with mannitol serum concentrations.

Edgar J García-Morales1, Rohit Cariappa, Curtis A Parvin, Mitchell G Scott, Michael N Diringer.   

Abstract

OBJECTIVE: To determine a) if the admission osmole gap, the difference between osmolality and osmolarity, is the same in the neurologic-neurosurgical intensive care unit (NNICU) population as in healthy controls; b) which of 11 osmole gap formulas, or osmolality, correlates best with mannitol serum concentrations; c) whether osmole gap correction for plasma water content improves this correlation; and d) whether the osmole gap can predict mannitol serum concentrations.
DESIGN: Prospectively collected data. SETTINGS: NNICU of a tertiary teaching hospital.
SUBJECTS: Ten NNICU patients on mannitol and eight not on mannitol, and 95 healthy controls.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We compared the admission osmole gap between all 18 NNICU patients and healthy controls and the correlation between osmole gap or osmolality and mannitol serum concentrations in ten NNICU patients while receiving mannitol. The osmole gap was calculated using 11 osmolarity formulas (six corrected for plasma water content). Student's t-test was used to compare the mean osmole gap between control and patient groups.We found that the mean osmole gap in healthy subjects and NNICU patients was not different. There were no statistically significant differences between any of the 11 osmole gap formulas and the correlation of osmole gap with serum mannitol concentrations; the highest R =.80, with formula 4, 1.86 (sodium + potassium) + (blood urea nitrogen/2.8) + (glucose/18) + 10, requires the least laboratory measurements. Osmolality had the lowest correlation with mannitol concentration (R =.60), significantly lower than any of the osmole gap calculations. Plasma water content correction did not improve this correlation. The osmole gap-mannitol serum concentrations relationship is 1 to 0.81, not accurate enough to predict specific mannitol serum concentrations.
CONCLUSIONS: The osmole gap correlates better with mannitol serum concentrations than osmolality, and although it cannot predict a specific mannitol serum concentration, a normal osmole gap concentration, as we find at trough times, indicates sufficient clearance for a new mannitol dose.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071390     DOI: 10.1097/01.ccm.0000120057.04528.60

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  19 in total

1.  Managing malignant cerebral infarction.

Authors:  J Marc Simard; Juan Sahuquillo; Kevin N Sheth; Kristopher T Kahle; Brian P Walcott
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.598

2.  [Recommendations of the European Stroke Initiative for the diagnosis and treatment of spontaneous intracerebral haemorrhage].

Authors:  S Külkens; P Ringleb; J Diedler; W Hacke; T Steiner
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

3.  Variation in osmotic response to sustained mannitol administration.

Authors:  Salah G Keyrouz; Rajat Dhar; Michael N Diringer
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

Review 4.  Management of intracranial pressure.

Authors:  Thomas J Wolfe; Michel T Torbey
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

5.  Treatment of malignant brain edema and increased intracranial pressure after stroke.

Authors:  Michael E Brogan; Edward M Manno
Journal:  Curr Treat Options Neurol       Date:  2015-01       Impact factor: 3.598

Review 6.  Harmonisation of Osmolal Gap - Can We Use a Common Formula?

Authors:  Kay Weng Choy; Nilika Wijeratne; Zhong X Lu; James Cg Doery
Journal:  Clin Biochem Rev       Date:  2016-08

7.  Treatment of brain edema in acute liver failure.

Authors:  Alejandro A Rabinstein
Journal:  Curr Treat Options Neurol       Date:  2010-03       Impact factor: 3.598

Review 8.  [Intensive care management [corrected] of patients with intracerebral hemorrhage].

Authors:  J Diedler; M Sykora; C Herweh; B Orakcioglu; K Zweckberger; T Steiner; W Hacke
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

Review 9.  Management of acute liver failure.

Authors:  R Todd Stravitz; David J Kramer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-08-04       Impact factor: 46.802

10.  Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo.

Authors:  Allan Jefferson Guimarães; Susana Frases; Radamés J B Cordero; Leonardo Nimrichter; Arturo Casadevall; Joshua D Nosanchuk
Journal:  Cell Microbiol       Date:  2010-01-11       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.